business

GoodRx vs. Hims & Hers Health: Stagnation vs. Growth in Revenue

Yahoo Finance · May 10, 2026, 12:44 PM · Also reported by 4 other sources

Read full story on Yahoo Finance → More top stories

Also covered by

Investing.com Hims & Hers reports surprise loss in Q1, shares dive after hours Investing.com Harrow Health earnings missed by $0.39, revenue fell short of estimates Investing.com Alkami Q1 2026 slides: revenue growth masks profitability concerns Investing.com Accendra Health earnings beat by $0.06, revenue fell short of estimates

Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

GoodRx vs. Hims & Hers Health: Stagnation vs. Growth in Revenue

Also covered by

More in business